Skip to main content
General Strike Anniversary
Coronavirus: the waiting period
Drastic public health measures against Covid-19 have not yet been implemented in Britain but are imminent. What do we do until then, asks SCIENCE AND SOCIETY

Control measures are crucial to reduce the overwhelming of the total healthcare system capacity by COVID-19

IN Illness as Metaphor, Susan Sontag wrote: “Any disease that is treated as a mystery and acutely enough feared will be felt to be morally, if not literally, contagious.” Although the Covid-19 situation is changing rapidly by the day — at the time of writing, five people have died in Britain and there are 319 confirmed cases — the disease has not yet truly arrived.

Normal life continues, nervously. For most people, Covid-19 remains a mystery and the main contagion is fear. So far, the government has held off putting in place drastic public health measures. Major disruption has not yet arrived. But with evidence from the spread elsewhere, it is certain that it will, and soon.

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
Similar stories
Hamnet
Opinion / 20 January 2026
20 January 2026

JULIA THOMAS unpicks the mental processes that explain why book-to-film adaptations so often disappoint

Prime Minister Keir Starmer speaks to British and Albanian troops about their involvement with training Ukrainian troops under Operation Interflex, during a visit to Berzite Military Museum in Tirana, Albania, May 15, 2025
Features / 15 July 2025
15 July 2025

In part one of a two-part feature, CONOR BOLLINS asks whether we should be concerned about the Prime Minister’s military recruitment plans

zb
Books / 27 June 2025
27 June 2025

ALEX DITTRICH hitches a ride on a jaw-dropping tour of the parasite world

POISON: Centivax workers study antivenom to counteract the bites of various snakes at the company lab in San Francisco
Science and Society / 7 May 2025
7 May 2025

A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT